Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Dear

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Trials|January 10, 2019
Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N-acetylcysteine for paracetamol overdose-the PP100-01 for Overdose of Paracetamol (POP) trial: study protocol for a randomised controlled trial, James Dear
Clinical Toxicology (Philadelphia, Pa.)|March 5, 2010
Medicine, poison, and mystic potion: a personal perspective on paracetamol Louis Roche lecture, Stockholm, 2009D Nicholas Bateman, James Dear
Lancet (London, England)|December 4, 2003
CalciphylaxisJames Dear, Joe Brookes, Martin Mansell, et al.
Journal of the American Society of Nephrology : JASN|June 24, 2004
Discovery of protein biomarkers for renal diseasesStephen M Hewitt, James Dear, Robert A Star
Clinical Medicine (London, England)|September 29, 2023
Duration of consultant experience and patient outcome following acute medical unit admission: an observational cohort studyMarcus J Lyall, James Dear, Johanne Simpson, et al.
Expert Review of Clinical Pharmacology|April 4, 2014
MicroRNAs as potential circulating biomarkers of drug-induced liver injury: key current and future issues for translation to humansRobert James Hornby, Philip Starkey Lewis, James Dear, et al.
British Journal of Clinical Pharmacology|January 12, 2011
An investigation into the effect of advice from the Scottish Medicines Consortium on the use of medicines in Scotland's Health ServiceMarion Bennie, James Dear, Sharon Hems, et al.
Emergency Medicine Journal : EMJ|February 14, 2023
Drink and injection spiking: how to approach an increase in presentations?Tess Blandamer, Jo Daniels, James Dear, et al.
Biology Open|October 17, 2019
The conserved metalloprotease invadolysin is present in invertebrate haemolymph and vertebrate bloodKanishk Abhinav, Linda Feng, Emma Morrison, et al.
Emergency Medicine Journal : EMJ|June 4, 2025
Nitazene detections and clinical characteristics: data from a prospective observational study in a Glasgow emergency departmentRufus Turner, Lisa Christine Dunlop, David John Lowe, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Trials|January 10, 2019
Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N-acetylcysteine for paracetamol overdose-the PP100-01 for Overdose of Paracetamol (POP) trial: study protocol for a randomised controlled trial, James Dear
Clinical Toxicology (Philadelphia, Pa.)|March 5, 2010
Medicine, poison, and mystic potion: a personal perspective on paracetamol Louis Roche lecture, Stockholm, 2009D Nicholas Bateman, James Dear
Lancet (London, England)|December 4, 2003
CalciphylaxisJames Dear, Joe Brookes, Martin Mansell, et al.
Journal of the American Society of Nephrology : JASN|June 24, 2004
Discovery of protein biomarkers for renal diseasesStephen M Hewitt, James Dear, Robert A Star
Clinical Medicine (London, England)|September 29, 2023
Duration of consultant experience and patient outcome following acute medical unit admission: an observational cohort studyMarcus J Lyall, James Dear, Johanne Simpson, et al.
Expert Review of Clinical Pharmacology|April 4, 2014
MicroRNAs as potential circulating biomarkers of drug-induced liver injury: key current and future issues for translation to humansRobert James Hornby, Philip Starkey Lewis, James Dear, et al.
British Journal of Clinical Pharmacology|January 12, 2011
An investigation into the effect of advice from the Scottish Medicines Consortium on the use of medicines in Scotland's Health ServiceMarion Bennie, James Dear, Sharon Hems, et al.
Emergency Medicine Journal : EMJ|February 14, 2023
Drink and injection spiking: how to approach an increase in presentations?Tess Blandamer, Jo Daniels, James Dear, et al.
Biology Open|October 17, 2019
The conserved metalloprotease invadolysin is present in invertebrate haemolymph and vertebrate bloodKanishk Abhinav, Linda Feng, Emma Morrison, et al.
Emergency Medicine Journal : EMJ|June 4, 2025
Nitazene detections and clinical characteristics: data from a prospective observational study in a Glasgow emergency departmentRufus Turner, Lisa Christine Dunlop, David John Lowe, et al.
Pageof 2